Triodos Investment Management’s Teladoc Health TDOC Stock Holding History

Triodos Investment Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-75,000	Closed	-$5.41M	–	48
2022 Q1	$5.41M	Hold	75,000	–	–	0.69%	35
2021 Q4	$6.89M	Hold	75,000	–	–	0.9%	33
2021 Q3	$9.51M	Buy	75,000 +10,000	+15%	+$1.46M	1.28%	32
2021 Q2	$10.8M	Buy	65,000 +30,000	+86%	+$4.86M	1.45%	32
2021 Q1	$6.36M	Hold	35,000	–	–	1.01%	32
2020 Q4	$7M	Hold	35,000	–	–	1.15%	31
2020 Q3	$7.67M	Hold	35,000	–	–	1.58%	25
2020 Q2	$6.68M	Sell	35,000 -5,000	-13%	-$876K	1.58%	23
2020 Q1	$6.2M	Sell	40,000 -34,000	-46%	-$3.96M	1.74%	21
2019 Q4	$6.2M	Sell	74,000 -11,000	-13%	-$837K	1.38%	25
2019 Q3	$5.76M	Hold	85,000	–	–	1.46%	25
2019 Q2	$5.64M	Hold	85,000	–	–	1.3%	25
2019 Q1	$4.73M	Sell	85,000 -15,000	-15%	-$916K	0.96%	33
2018 Q4	$4.96M	Sell	100,000 -35,000	-26%	-$2.14M	1.07%	31
2018 Q3	$11.7M	Sell	135,000 -25,000	-16%	-$1.78M	2.02%	23
2018 Q2	$9.29M	Buy	+160,000	New	+$7.81M	1.74%	25

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

Triodos Investment Management's TDOC Position: Q2 2022 in Review

Triodos Investment Management sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 75,000 shares — an estimated $5.41M sold.

Triodos Investment Management first reported a position in TDOC in Q2 2018 and held it in 16 quarters. The position peaked at $11.7M in Q3 2018. 550 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

Triodos Investment Management reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
Triodos Investment Management sold 75,000 Teladoc Health shares in Q2 2022, an estimated $5.41M.
Triodos Investment Management first reported a position in Teladoc Health in Q2 2018 and held it in 16 quarters.
Triodos Investment Management's Teladoc Health position peaked at $11.7M in Q3 2018.
550 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Triodos Investment Management's 13F filing for Q2 2022, filed 8 Aug 2022.